Ina Weiner - Publications

Affiliations: 
Tel Aviv University, Tel Aviv-Yafo, Tel Aviv District, Israel 
Area:
Latent inhibition, animal models of schizophrenia, behavioral neuroscience

134 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ben-Shachar D, Ene H, Karry R, Weiner I. Neuronal and Behavioral Abnormalities in Schizophrenia Derived Cells and Animal Model are Amended by Mitochondria Transplantation Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.235  0.344
2019 Di Biase MA, Katabi G, Piontkewitz Y, Cetin-Karayumak S, Weiner I, Pasternak O. Increased extracellular free-water in adult male rats following in utero exposure to maternal immune activation. Brain, Behavior, and Immunity. PMID 31521731 DOI: 10.1016/j.bbi.2019.09.010  0.347
2019 Weiner I, Piontkewitz Y, Arad M. 40.4 Effective Early Intervention With Risperidone Or Clozapine In Female Rats Prenatally Exposed To Poly-I:C: Must Take Place Before The Emergence Of Behavioral Abnormalities And Requires Normalization Of Structural Deficits Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz022.167  0.371
2019 Weiner I. 40. Early Intervention Is Effective In Halting Developmental Neuropathology And Behavioral Deficits: Lessons From Model Rodents Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz022.163  0.309
2018 Piontkewitz Y, Arad M, Weiner I. T194. Brain Structural And Behavioral Abnormalities Following Prenatal Exposure To Maternal Inflammation Are Prevented By Early But Not Late Intervention. Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby016.470  0.511
2017 Robicsek O, Ene HM, Karry R, Ytzhaki O, Asor E, McPhie D, Cohen BM, Ben-Yehuda R, Weiner I, Ben-Shachar D. Isolated Mitochondria Transfer Improves Neuronal Differentiation of Schizophrenia-Derived Induced Pluripotent Stem Cells and Rescues Deficits in a Rat Model of the Disorder. Schizophrenia Bulletin. PMID 28586483 DOI: 10.1093/Schbul/Sbx077  0.338
2017 Hadar R, Bikovski L, Soto-Montenegro ML, Schimke J, Maier P, Ewing S, Voget M, Wieske F, Götz T, Desco M, Hamani C, Pascau J, Weiner I, Winter C. Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia. Molecular Psychiatry. 23: 943-951. PMID 28373685 DOI: 10.1038/Mp.2017.52  0.435
2017 Arad M, Piontkewitz Y, Albelda N, Shaashua L, Weiner I. Immune activation in lactating dams alters sucklings' brain cytokines and produces non-overlapping behavioral deficits in adult female and male offspring: A novel neurodevelopmental model of sex-specific psychopathology. Brain, Behavior, and Immunity. PMID 28189716 DOI: 10.1016/J.Bbi.2017.01.015  0.585
2016 Bikovsky L, Hadar R, Soto-Montenegro ML, Klein J, Weiner I, Desco M, Pascau J, Winter C, Hamani C. Deep brain stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia. Experimental Neurology. PMID 27302677 DOI: 10.1016/J.Expneurol.2016.06.012  0.416
2016 Hadar R, Bikovsky L, Soto-Montenegro M, Klein J, Weiner I, Pascau J, Hamani C, Winter C. EP 18. Deep Brain Stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia Clinical Neurophysiology. 127. DOI: 10.1016/J.Clinph.2016.05.211  0.396
2015 Patrich E, Piontkewitz Y, Peretz A, Weiner I, Attali B. Maturation- and sex-sensitive depression of hippocampal excitatory transmission in a rat schizophrenia model. Brain, Behavior, and Immunity. PMID 26327125 DOI: 10.1016/j.bbi.2015.08.021  0.339
2015 Hadar R, Soto-Montenegro ML, Götz T, Wieske F, Sohr R, Desco M, Hamani C, Weiner I, Pascau J, Winter C. Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course. Schizophrenia Research. 166: 238-47. PMID 26055633 DOI: 10.1016/J.Schres.2015.05.010  0.431
2013 Klein J, Hadar R, Götz T, Männer A, Eberhardt C, Baldassarri J, Schmidt TT, Kupsch A, Heinz A, Morgenstern R, Schneider M, Weiner I, Winter C. Mapping brain regions in which deep brain stimulation affects schizophrenia-like behavior in two rat models of schizophrenia. Brain Stimulation. 6: 490-9. PMID 23085443 DOI: 10.1016/J.Brs.2012.09.004  0.41
2012 Griebel G, Pichat P, Pruniaux MP, Beeské S, Lopez-Grancha M, Genet E, Terranova JP, Castro A, Sánchez JA, Black M, Varty GB, Weiner I, Arad M, Barak S, De Levie A, et al. SAR110894, a potent histamine H₃-receptor antagonist, displays procognitive effects in rodents. Pharmacology, Biochemistry, and Behavior. 102: 203-14. PMID 22542742 DOI: 10.1016/J.Pbb.2012.04.004  0.707
2012 Piontkewitz Y, Bernstein HG, Dobrowolny H, Bogerts B, Weiner I, Keilhoff G. Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats. Brain, Behavior, and Immunity. 26: 353-63. PMID 22154704 DOI: 10.1016/j.bbi.2011.11.004  0.355
2012 Arad M, Weiner I. Abnormally rapid reversal learning and reduced response to antipsychotic drugs following ovariectomy in female rats. Psychoneuroendocrinology. 37: 200-12. PMID 21723667 DOI: 10.1016/J.Psyneuen.2011.06.004  0.646
2012 Piontkewitz Y, Arad M, Weiner I. Tracing the development of psychosis and its prevention: what can be learned from animal models. Neuropharmacology. 62: 1273-89. PMID 21703648 DOI: 10.1016/J.Neuropharm.2011.04.019  0.607
2011 Piontkewitz Y, Arad M, Weiner I. Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat. Biological Psychiatry. 70: 842-51. PMID 21816387 DOI: 10.1016/J.Biopsych.2011.06.007  0.581
2011 Barak S, Weiner I. Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target. Pharmacology, Biochemistry, and Behavior. 99: 164-89. PMID 21420999 DOI: 10.1016/J.Pbb.2011.03.011  0.627
2011 Barak S, Weiner I. The M₁/Mâ‚„ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 1233-46. PMID 21211109 DOI: 10.1017/S1461145710001549  0.681
2011 Black MD, Stevens RJ, Rogacki N, Featherstone RE, Senyah Y, Giardino O, Borowsky B, Stemmelin J, Cohen C, Pichat P, Arad M, Barak S, De Levie A, Weiner I, Griebel G, et al. AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents. Psychopharmacology. 215: 149-63. PMID 21181124 DOI: 10.1007/S00213-010-2124-0  0.727
2011 Meyer U, Weiner I, McAlonan GM, Feldon J. The neuropathological contribution of prenatal inflammation to schizophrenia. Expert Review of Neurotherapeutics. 11: 29-32. PMID 21158552 DOI: 10.1586/Ern.10.169  0.348
2011 Piontkewitz Y, Arad M, Weiner I. Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. Schizophrenia Bulletin. 37: 1257-69. PMID 20439320 DOI: 10.1093/Schbul/Sbq040  0.613
2010 Arad M, Weiner I. Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2179-92. PMID 20613719 DOI: 10.1038/Npp.2010.89  0.639
2010 Arad M, Weiner I. Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1570-82. PMID 20237462 DOI: 10.1038/Npp.2010.28  0.643
2010 Barak S, Weiner I. Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine. Psychopharmacology. 209: 175-84. PMID 20179909 DOI: 10.1007/S00213-010-1785-Z  0.681
2010 Barak S, Weiner I. Differential role of muscarinic transmission within the entorhinal cortex and basolateral amygdala in the processing of irrelevant stimuli. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1073-82. PMID 20072122 DOI: 10.1038/Npp.2009.210  0.644
2010 Lubow RE, Weiner I. Issues in latent inhibition research and theory: An overview Latent Inhibition: Cognition, Neuroscience and Applications to Schizophrenia. 531-557. DOI: 10.1017/CBO9780511730184.023  0.511
2010 Weiner I, Arad M. The pharmacology of latent inhibition and its relevance to schizophrenia Latent Inhibition: Cognition, Neuroscience and Applications to Schizophrenia. 276-318. DOI: 10.1017/CBO9780511730184.014  0.545
2010 Lubow RE, Weiner I. Preface Latent Inhibition: Cognition, Neuroscience and Applications to Schizophrenia. xi-xii. DOI: 10.1017/CBO9780511730184.001  0.487
2010 Lubow RE, Weiner I. Latent inhibition: Cognition, neuroscience and applications to schizophrenia Latent Inhibition: Cognition, Neuroscience and Applications to Schizophrenia. 1-561. DOI: 10.1017/CBO9780511730184  0.611
2009 Piontkewitz Y, Assaf Y, Weiner I. Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. Biological Psychiatry. 66: 1038-46. PMID 19726031 DOI: 10.1016/j.biopsych.2009.07.005  0.43
2009 Weiner I, Arad M. Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment. Behavioural Brain Research. 204: 369-86. PMID 19433114 DOI: 10.1016/J.Bbr.2009.05.004  0.653
2009 Arad M, Weiner I. Disruption of latent inhibition induced by ovariectomy can be reversed by estradiol and clozapine as well as by co-administration of haloperidol with estradiol but not by haloperidol alone. Psychopharmacology. 206: 731-40. PMID 19169876 DOI: 10.1007/S00213-009-1464-0  0.637
2009 Barak S, Arad M, De Levie A, Black MD, Griebel G, Weiner I. Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1753-63. PMID 19158670 DOI: 10.1038/Npp.2008.232  0.752
2009 Black MD, Varty GB, Arad M, Barak S, De Levie A, Boulay D, Pichat P, Griebel G, Weiner I. Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology. 202: 385-96. PMID 18709358 DOI: 10.1007/S00213-008-1289-2  0.759
2009 Barak S, Weiner I. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 227-41. PMID 18687163 DOI: 10.1017/S1461145708009176  0.668
2008 Arad M, Weiner I. Fluctuation of latent inhibition along the estrous cycle in the rat: modeling the cyclicity of symptoms in schizophrenic women? Psychoneuroendocrinology. 33: 1401-10. PMID 18819755 DOI: 10.1016/J.Psyneuen.2008.08.001  0.618
2008 Gaisler-Salomon I, Diamant L, Rubin C, Weiner I. Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered. Psychopharmacology. 196: 255-67. PMID 17928997 DOI: 10.1007/s00213-007-0960-3  0.77
2008 Weiner I, Piontkewitz Y, Yaniv A. Prevention Of Post-Pubertal Schizophrenia-Like Behavior And Neuropathology During The Prodrome In The Maternal Immune Activation Model Schizophrenia Research. 102: 31. DOI: 10.1016/S0920-9964(08)70099-9  0.371
2007 Barak S, Weiner I. Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 989-99. PMID 16971898 DOI: 10.1038/Sj.Npp.1301208  0.7
2006 Schiller D, Zuckerman L, Weiner I. Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol. Journal of Psychiatric Research. 40: 167-77. PMID 15882871 DOI: 10.1016/j.jpsychires.2005.03.002  0.768
2006 Tarrasch R, Goelman G, Joel D, Weiner I. Erratum to “Long-term functional consequences of quinolinic acid striatal lesions and their alteration following an addition of a globus pallidus lesion assessed using pharmacological magnetic resonance imaging” [Exp. Neurol. 196 (2005) 244–253] Experimental Neurology. 202: 522. DOI: 10.1016/j.expneurol.2006.01.029  0.506
2005 Tarrasch R, Goelman G, Joel D, Daphna J, Weiner I. Long-term functional consequences of quinolinic acid striatal lesions and their alteration following an addition of a globus pallidus lesion assessed using pharmacological magnetic resonance imaging. Experimental Neurology. 196: 244-53. PMID 16236282 DOI: 10.1016/j.expneurol.2005.07.023  0.57
2005 Gal G, Schiller D, Weiner I. Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: The neural site controlling the expression and disruption of the stimulus preexposure effect. Behavioural Brain Research. 162: 246-55. PMID 15970218 DOI: 10.1016/j.bbr.2005.03.019  0.617
2005 Schiller D, Weiner I. Basolateral amygdala lesions in the rat produce an abnormally persistent latent inhibition with weak preexposure but not with context shift. Behavioural Brain Research. 163: 115-21. PMID 15921766 DOI: 10.1016/j.bbr.2005.04.005  0.621
2005 Lipina T, Labrie V, Weiner I, Roder J. Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology. 179: 54-67. PMID 15759151 DOI: 10.1007/S00213-005-2210-X  0.423
2005 Zuckerman L, Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. Journal of Psychiatric Research. 39: 311-23. PMID 15725430 DOI: 10.1016/j.jpsychires.2004.08.008  0.645
2004 Schiller D, Weiner I. Lesions to the basolateral amygdala and the orbitofrontal cortex but not to the medial prefrontal cortex produce an abnormally persistent latent inhibition in rats. Neuroscience. 128: 15-25. PMID 15450350 DOI: 10.1016/j.neuroscience.2004.06.020  0.62
2004 Cohen E, Sereni N, Kaplan O, Weizman A, Kikinzon L, Weiner I, Lubow RE. The relation between latent inhibition and symptom-types in young schizophrenics. Behavioural Brain Research. 149: 113-22. PMID 15129775 DOI: 10.1016/S0166-4328(03)00221-3  0.642
2004 Ayalon L, Doron R, Weiner I, Joel D. Amelioration of behavioral deficits in a rat model of Huntington's disease by an excitotoxic lesion to the globus pallidus. Experimental Neurology. 186: 46-58. PMID 14980809 DOI: 10.1016/S0014-4886(03)00312-1  0.752
2004 Pouzet B, Zhang WN, Weiner I, Feldon J, Yee BK. Latent inhibition is spared by N-methyl-D-aspartate (NMDA)-induced ventral hippocampal lesions, but is attenuated following local activation of the ventral hippocampus by intracerebral NMDA infusion. Neuroscience. 124: 183-94. PMID 14960350 DOI: 10.1016/J.Neuroscience.2003.11.007  0.405
2003 Joel D, Ayalon L, Tarrasch R, Weiner I. Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: a potential novel treatment in a rat model of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1499-507. PMID 14673887 DOI: 10.1002/mds.10622  0.576
2003 Zuckerman L, Rehavi M, Nachman R, Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1778-89. PMID 12865897 DOI: 10.1038/sj.npp.1300248  0.677
2003 Zuckerman L, Rimmerman N, Weiner I. Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia. Psychopharmacology. 169: 298-307. PMID 12827344 DOI: 10.1007/S00213-003-1460-8  0.709
2003 Weiner I, Schiller D, Gaisler-Salomon I, Green A, Joel D. A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine. Behavioural Pharmacology. 14: 215-22. PMID 12799523 DOI: 10.1097/01.fbp.0000069579.37661.63  0.804
2003 Zuckerman L, Weiner I. Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation. Psychopharmacology. 169: 308-13. PMID 12748757 DOI: 10.1007/s00213-003-1461-7  0.664
2003 Weiner I, Schiller D, Gaisler-Salomon I. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 499-509. PMID 12629529 DOI: 10.1038/sj.npp.1300069  0.789
2003 Weiner I. The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology. 169: 257-97. PMID 12601500 DOI: 10.1007/s00213-002-1313-x  0.533
2003 Gaisler-Salomon I, Weiner I. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Psychopharmacology. 166: 333-42. PMID 12599023 DOI: 10.1007/s00213-002-1311-z  0.787
2002 Weiner I, Joel D. Dopamine in Schizophrenia Dysfunctional Information Processing in Basal Ganglia — Thalamocortical Split Circuits Handbook of Experimental Pharmacology. 154: 417-471. DOI: 10.1007/978-3-662-06765-9_13  0.556
2001 Weiner I. Latent inhibition. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.13. PMID 18428541 DOI: 10.1002/0471142301.ns0813s16  0.474
2001 Shalev U, Weiner I. Gender-dependent differences in latent inhibition following prenatal stress and corticosterone administration. Behavioural Brain Research. 126: 57-63. PMID 11704252 DOI: 10.1016/S0166-4328(01)00250-9  0.44
2000 Shadach E, Gaisler I, Schiller D, Weiner I. The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 151-61. PMID 10882841 DOI: 10.1016/S0893-133X(00)00096-8  0.647
2000 Joel D, Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience. 96: 451-74. PMID 10717427 DOI: 10.1016/S0306-4522(99)00575-8  0.524
2000 Lacroix L, Broersen LM, Feldon J, Weiner I. Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behavioural Brain Research. 107: 111-21. PMID 10628735 DOI: 10.1016/S0166-4328(99)00118-7  0.446
2000 Weiner I, Gaisler I, Schiller D, Green A, Zuckerman L, Joel D. Screening of antipsychotic drugs in animal models Drug Development Research. 50: 235-249. DOI: 10.1002/1098-2299(200007/08)50:3/4<235::Aid-Ddr7>3.0.Co;2-R  0.766
1999 Shadach E, Feldon J, Weiner I. Clozapine-induced potentiation of latent inhibition is due to its action in the conditioning stage: implications for the mechanism of action of antipsychotic drugs. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 2: 283-291. PMID 11285144 DOI: 10.1017/S1461145799001583  0.442
1999 Broersen LM, Feldon J, Weiner I. Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion. Neuroscience. 94: 39-46. PMID 10613495 DOI: 10.1016/S0306-4522(99)00287-0  0.393
1999 Zhang W, Pouzet B, Jongen-Rêlo AL, Weiner I, Feldon J. Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: a possible model for the screening of atypical antipsychotics. Neuroreport. 10: 2533-8. PMID 10574365 DOI: 10.1097/00001756-199908200-00018  0.464
1999 Pouzet B, Veenman CL, Yee BK, Feldon J, Weiner I. The effects of radiofrequency lesion or transection of the fimbria-fornix on latent inhibition in the rat. Neuroscience. 91: 1355-68. PMID 10391442 DOI: 10.1016/S0306-4522(98)00691-5  0.412
1998 Shalev U, Feldon J, Weiner I. Latent inhibition is disrupted by acute and repeated administration of corticosterone. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 1: 103-113. PMID 11281953 DOI: 10.1017/S1461145798001163  0.435
1998 Ruob C, Weiner I, Feldon J. Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning. Behavioural Pharmacology. 9: 245-53. PMID 9832938  0.339
1998 Weiner I, Feldon J, Tarrasch R, Hairston I, Joel D. Fimbria-fornix cut affects spontaneous activity, two-way avoidance and delayed non matching to sample, but not latent inhibition. Behavioural Brain Research. 96: 59-70. PMID 9821543 DOI: 10.1016/S0166-4328(97)00193-9  0.589
1998 Shalev U, Feldon J, Weiner I. Gender- and age-dependent differences in latent inhibition following pre-weaning non-handling: implications for a neurodevelopmental animal model of schizophrenia. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 16: 279-88. PMID 9785124 DOI: 10.1016/S0736-5748(98)00031-8  0.443
1998 Stöhr T, Schulte Wermeling D, Szuran T, Pliska V, Domeney A, Welzl H, Weiner I, Feldon J. Differential effects of prenatal stress in two inbred strains of rats. Pharmacology, Biochemistry, and Behavior. 59: 799-805. PMID 9586834 DOI: 10.1016/S0091-3057(97)00541-8  0.303
1998 Lacroix L, Broersen LM, Weiner I, Feldon J. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience. 84: 431-42. PMID 9539214 DOI: 10.1016/S0306-4522(97)00521-6  0.401
1998 Joel D, Ayalon L, Tarrasch R, Veenman L, Feldon J, Weiner I. Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease. Brain Research. 787: 143-8. PMID 9518584 DOI: 10.1016/S0006-8993(97)01428-5  0.552
1998 Weiner I, Hairston I, Shayit M, Feldman G, Joel D, Feldon J. Strain differences in latent inhibition Psychobiology. 26: 57-64. DOI: 10.3758/Bf03330592  0.612
1997 Ruob C, Elsner J, Weiner I, Feldon J. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus. Behavioural Brain Research. 88: 35-41. PMID 9401706 DOI: 10.1016/S0166-4328(97)02305-X  0.428
1997 Weiner I, Feldon J. The switching model of latent inhibition: an update of neural substrates. Behavioural Brain Research. 88: 11-25. PMID 9401704 DOI: 10.1016/S0166-4328(97)02314-0  0.48
1997 Joel D, Tarrasch R, Feldon J, Weiner I. Effects of electrolytic lesions of the medial prefrontal cortex or its subfields on 4-arm baited, 8-arm radial maze, two-way active avoidance and conditioned fear tasks in the rat. Brain Research. 765: 37-50. PMID 9310392 DOI: 10.1016/S0006-8993(97)00334-X  0.581
1997 Vaid RR, Yee BK, Shalev U, Rawlins JN, Weiner I, Feldon J, Totterdell S. Neonatal nonhandling and in utero prenatal stress reduce the density of NADPH-diaphorase-reactive neurons in the fascia dentata and Ammon's horn of rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 5599-609. PMID 9204941 DOI: 10.1523/Jneurosci.17-14-05599.1997  0.342
1997 Weiner I, Tarrasch R, Bernasconi E, Broersen LM, Rüttimann TC, Feldon J. Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated. Pharmacology, Biochemistry, and Behavior. 56: 817-26. PMID 9130310 DOI: 10.1016/S0091-3057(96)00417-0  0.439
1997 Gal G, Joel D, Gusak O, Feldon J, Weiner I. The effects of electrolytic lesion to the shell subterritory of the nucleus accumbens on delayed non-matching-to-sample and four-arm baited eight-arm radial-maze tasks. Behavioral Neuroscience. 111: 92-103. PMID 9109627 DOI: 10.1037//0735-7044.111.1.92  0.502
1997 Joel D, Weiner I, Feldon J. Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance on an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: implications for animal models of schizophrenia. Behavioural Brain Research. 85: 187-201. PMID 9105575 DOI: 10.1016/S0166-4328(97)87583-3  0.625
1997 Joel D, Weiner I. The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry. Brain Research. Brain Research Reviews. 23: 62-78. PMID 9063587 DOI: 10.1016/S0165-0173(96)00018-5  0.492
1997 Weiner I, Shadach E, Barkai R, Feldon J. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 16: 42-50. PMID 8981387 DOI: 10.1016/S0893-133X(96)00145-5  0.47
1997 Weiner I, Barkai R, Eitani Y, Feldon J. Individual differences in latent inhibition in rats Neuroscience Letters. 237: S52. DOI: 10.1016/S0304-3940(97)90213-5  0.333
1997 Tarrasch R, Joel D, Feldon J, Weiner I. Electrolytic lesion of the globus pallidus reduces the neurodegenerative effects of quinolinic acid lesion of the striatum in the rat Neuroscience Letters. 237: S49-S50. DOI: 10.1016/S0304-3940(97)90202-0  0.542
1997 Shalev U, Feldon J, Weiner I. The effects of chronic corticosterone administration on amphetamine-induced activity, spatial learning and latent inhibition (LI) Neuroscience Letters. 237: S45. DOI: 10.1016/S0304-3940(97)90184-1  0.341
1997 Ayalon L, Joel D, Tarrasch R, Feldon J, Weiner I. Electrolytic lesion of globus pallidus ameliorates the behavioral effects of quinolinic acid lesion of the striatum: A potential novel treatment in a rat model of Huntington's disease Neuroscience Letters. 237: S5. DOI: 10.1016/S0304-3940(97)90019-7  0.559
1996 Weiner I, Gal G, Rawlins JN, Feldon J. Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity. Behavioural Brain Research. 81: 123-33. PMID 8950008 DOI: 10.1016/S0166-4328(96)00051-4  0.414
1996 Weiner I, Shadach E, Tarrasch R, Kidron R, Feldon J. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine. Biological Psychiatry. 40: 834-43. PMID 8896769 DOI: 10.1016/0006-3223(95)00573-0  0.529
1995 Weiner I, Traub A, Rawlins JN, Smith AD, Feldon J. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats. Behavioural Pharmacology. 6: 46-54. PMID 11224311  0.378
1995 Weiner I, Tarrasch R, Feldon J. Basolateral amygdala lesions do not disrupt latent inhibition. Behavioural Brain Research. 72: 73-81. PMID 8788859 DOI: 10.1016/0166-4328(96)00056-3  0.47
1995 Weiner I, Traub A, Rawlins JN, Smith AD, Feldon J. The sigma ligand BMY-14802 as a potential antipsychotic Behavioural Pharmacology. 6: 46???54. DOI: 10.1097/00008877-199501000-00008  0.468
1994 Weiner I, Tarrasch R, Hasson O, Forian R, Smith AD, Rawlins JN, Feldon J. The effects of chronic administration of ceronapril on the partial reinforcement extinction effect and latent inhibition in rats. Behavioural Pharmacology. 5: 306-314. PMID 11224280 DOI: 10.1097/00008877-199406000-00008  0.441
1994 Weiner I, Kidron R, Tarrasch R, Arnt J, Feldon J. The effects of the new antipsychotic, sertindole, on latent inhibition in rats. Behavioural Pharmacology. 5: 119-124. PMID 11224259 DOI: 10.1097/00008877-199404000-00002  0.489
1994 Weiner I, Feldon J. The latent inhibition model of schizophrenic attention disorder and of antipsychotic drug action: comment on Dunn, Atwater and Kilts (Psychopharmacology, 1993, 112:315-323) Psychopharmacology. 116: 379-81. PMID 7892430 DOI: 10.1007/BF02245344  0.35
1994 Joel D, Weiner I. The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience. 63: 363-79. PMID 7891852 DOI: 10.1016/0306-4522(94)90536-3  0.468
1994 Warburton EC, Joseph MH, Feldon J, Weiner I, Gray JA. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron. Psychopharmacology. 114: 657-64. PMID 7855229 DOI: 10.1007/BF02244998  0.454
1992 Feldon J, Weiner I. Amphetamine and the multitrial partial reinforcement extinction effect (PREE) in an operant chamber: procedural modifications that lead to an attenuation of the PREE. Pharmacology, Biochemistry, and Behavior. 41: 309-15. PMID 1574519 DOI: 10.1016/0091-3057(92)90103-M  0.321
1992 Weiner I, Feldon J. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia. Pharmacology, Biochemistry, and Behavior. 42: 625-31. PMID 1513845 DOI: 10.1016/0091-3057(92)90008-4  0.479
1992 Feldon J, Weiner I. From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. Journal of Psychiatric Research. 26: 345-66. PMID 1491358 DOI: 10.1016/0022-3956(92)90040-U  0.507
1992 Weiner I, Smith AD, Rawlins JN, Feldon J. A neuroleptic-like effect of ceronapril on latent inhibition. Neuroscience. 49: 307-15. PMID 1359453 DOI: 10.1016/0306-4522(92)90098-M  0.467
1991 Feldon J, Weiner I. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli. Biological Psychiatry. 29: 635-46. PMID 2054435 DOI: 10.1016/0006-3223(91)90133-7  0.484
1991 Feldon J, Weiner I. Effects of haloperidol on the multitrial partial reinforcement extinction effect (PREE): evidence for neuroleptic drug action on nonreinforcement but not on reinforcement. Psychopharmacology. 105: 407-14. PMID 1686816 DOI: 10.1007/BF02244437  0.385
1991 Feldon J, Shofel A, Weiner I. Latent inhibition is unaffected by direct dopamine agonists. Pharmacology, Biochemistry, and Behavior. 38: 309-14. PMID 1676170 DOI: 10.1016/0091-3057(91)90283-8  0.386
1990 Weiner I. Neural substrates of latent inhibition: the switching model. Psychological Bulletin. 108: 442-61. PMID 1980149 DOI: 10.1037/0033-2909.108.3.442  0.425
1989 Feldon J, Weiner I. The effects of amphetamine on a multitrial partial reinforcement extinction effect (PREE) in an operant chamber. Pharmacology, Biochemistry, and Behavior. 32: 65-9. PMID 2734352 DOI: 10.1016/0091-3057(89)90211-6  0.339
1989 Feldon J, Bercovitz H, Weiner I. The effects of amphetamine on a multitrial partial reinforcement extinction effect (PREE) in a runway. Pharmacology, Biochemistry, and Behavior. 32: 55-63. PMID 2734351 DOI: 10.1016/0091-3057(89)90210-4  0.387
1989 Feldon J, Weiner I. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats. Pharmacology, Biochemistry, and Behavior. 32: 123-7. PMID 2734324 DOI: 10.1016/0091-3057(89)90220-7  0.444
1988 Weiner I, Lubow RE, Feldon J. Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacology, Biochemistry, and Behavior. 30: 871-8. PMID 3227035 DOI: 10.1016/0091-3057(88)90113-X  0.669
1988 Feldon J, Weiner I. Long-term attentional deficit in nonhandled males: possible involvement of the dopaminergic system. Psychopharmacology. 95: 231-6. PMID 3137603 DOI: 10.1007/BF00174515  0.374
1988 Feldon J, Katz Y, Weiner I. The effects of haloperidol on the partial reinforcement extinction effect (PREE): implications for neuroleptic drug action on reinforcement and nonreinforcement. Psychopharmacology. 95: 528-33. PMID 2905502 DOI: 10.1007/BF00172968  0.397
1987 Weiner I, Feldon J, Bercovitz H. The abolition of the partial reinforcement extinction effect (PREE) by amphetamine: disruption of control by nonreinforcement. Pharmacology, Biochemistry, and Behavior. 27: 205-10. PMID 3628434 DOI: 10.1016/0091-3057(87)90558-2  0.343
1987 Weiner I, Feldon J, Ziv-Harris D. Early handling and latent inhibition in the conditioned suppression paradigm. Developmental Psychobiology. 20: 233-40. PMID 3582782 DOI: 10.1002/dev.420200211  0.394
1987 Weiner I, Feldon J, Katz Y. Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats. Pharmacology, Biochemistry, and Behavior. 26: 241-6. PMID 3575349 DOI: 10.1016/0091-3057(87)90112-2  0.454
1987 Weiner I, Feldon J, Ben-Horin E. Facilitation of discrimination transfers under amphetamine: the relative control by S+ and S- and general transfer effects. Psychopharmacology. 93: 261-7. PMID 3122260 DOI: 10.1007/BF00179945  0.33
1987 Weiner I, Feldon J. Facilitation of latent inhibition by haloperidol in rats. Psychopharmacology. 91: 248-53. PMID 3107041 DOI: 10.1007/BF00217073  0.444
1987 Weiner I, Izraeli-Telerant A, Feldon J. Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine. Psychopharmacology. 91: 345-51. PMID 3104957 DOI: 10.1007/BF00518189  0.443
1987 Lubow RE, Weiner I, Schlossberg A, Baruch I. Latent inhibition and schizophrenia Bulletin of the Psychonomic Society. 25: 464-467. DOI: 10.3758/BF03334742  0.677
1987 Ohad D, Lubow RE, Weiner I, Feldon J. The effects of amphetamine on blocking Psychobiology. 15: 137-143. DOI: 10.3758/BF03333102  0.662
1986 Weiner I, Feldon J, Ben-Shahar O. Simultaneous brightness discrimination and reversal: the effects of amphetamine administration in the two stages. Pharmacology, Biochemistry, and Behavior. 25: 939-42. PMID 3786368 DOI: 10.1016/0091-3057(86)90066-3  0.35
1986 Weiner I, Ben Horin E, Feldon J. Amphetamine and the overtraining reversal effect. Pharmacology, Biochemistry, and Behavior. 24: 1539-42. PMID 3737622 DOI: 10.1016/0091-3057(86)90481-8  0.369
1986 Halevy G, Feldon J, Weiner I. The effects of clonidine on the partial reinforcement extinction effect (PREE). Psychopharmacology. 90: 95-100. PMID 3094069 DOI: 10.1007/BF00172878  0.38
1986 Weiner I, Feldon J. Reversal and nonreversal shifts under amphetamine. Psychopharmacology. 89: 355-9. PMID 3088663 DOI: 10.1007/BF00174374  0.376
1986 Weiner I, Bercovitz H, Feldon J. Amphetamine does not affect the partial punishment effect (PPE). Psychopharmacology. 88: 119-23. PMID 3080770 DOI: 10.1007/BF00310526  0.346
1985 Weiner I, Schnabel I, Lubow RE, Feldon J. The effects of early handling on latent inhibition in male and female rats. Developmental Psychobiology. 18: 291-7. PMID 4043546 DOI: 10.1002/dev.420180402  0.643
1985 Weiner I, Bercovitz H, Lubow RE, Feldon J. The abolition of the partial reinforcement extinction effect (PREE) by amphetamine. Psychopharmacology. 86: 318-23. PMID 3929302 DOI: 10.1007/BF00432221  0.656
1984 Weiner I, Lubow RE, Feldon J. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology. 83: 194-9. PMID 6431473 DOI: 10.1007/BF00429734  0.723
1981 Weiner I, Lubow R, Feldon J. Chronic amphetamine and latent inhibition Behavioural Brain Research. 2: 285-286. DOI: 10.1016/0166-4328(81)90105-4  0.61
1979 Caspy T, Frommer R, Weiner I, Lubow RE. Generality of US preexposure effects: Effect of shock or food preexposure on water escape Bulletin of the Psychonomic Society. 14: 15-18. DOI: 10.3758/BF03329386  0.587
Show low-probability matches.